Stem Cell Therapy for Treatment of Ocular Disorders

Figure 4

Tracking of injected human Wharton’s jelly-derived MSCs in an RP rat model (Royal College of Surgeons rats) with microcomputed tomography. Microcomputed tomography images show localization of gold-loaded human Wharton’s jelly-derived MSCs in the right eye (a) on day one. The cells were found to be retained in the eye without further migration at day thirty (b) and day seventy (c) after transplantation. PKH 26 (labelled red) indicated the subretinal site of human Wharton’s jelly-derived MSCs after cell transplantation at week two. Modified with permission from Creative Commons Attribution License [103].